These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 9408013

  • 1. Levels of prothrombin fragment F1+2 in patients with hyperhomocysteinemia and a history of venous thromboembolism.
    Kyrle PA, Stümpflen A, Hirschl M, Bialonczyk C, Herkner K, Speiser W, Weltermann A, Kaider A, Pabinger I, Lechner K, Eichinger S.
    Thromb Haemost; 1997 Nov; 78(5):1327-31. PubMed ID: 9408013
    [Abstract] [Full Text] [Related]

  • 2. Prothrombin fragment F1+2 is not predictive for recurrent venous thromboembolism.
    Kyrle PA, Eichinger S, Pabinger I, Stümpflen A, Hirschl M, Bialonczyk C, Schneider B, Mannhalter C, Melichart M, Traxler G, Weltermann A, Speiser W, Lechner K.
    Thromb Haemost; 1997 May; 77(5):829-33. PubMed ID: 9184387
    [Abstract] [Full Text] [Related]

  • 3. Withdrawal of warfarin after deep vein thrombosis: effects of a low fixed dose on rebound thrombin generation.
    Ascani A, Iorio A, Agnelli G.
    Blood Coagul Fibrinolysis; 1999 Jul; 10(5):291-5. PubMed ID: 10456621
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A, Della Valle P, Crippa L, Fattorini A, Pattarini E, Viganò D'Angelo S.
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Koster T, Bertina RM, Vandenbroucke JP.
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [Abstract] [Full Text] [Related]

  • 11. Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency.
    Zöller B, Holm J, Svensson P, Dahlbäck B.
    Thromb Haemost; 1996 Feb; 75(2):270-4. PubMed ID: 8815575
    [Abstract] [Full Text] [Related]

  • 12. Effect of different oral anticoagulant intensities on prothrombin fragment 1 + 2 in Thai patients with mechanical heart valve prostheses.
    Tientadakul P, Opartkiattikul N, Sangtawesin W, Sakiyalak P.
    J Med Assoc Thai; 1997 Feb; 80(2):81-6. PubMed ID: 9078691
    [Abstract] [Full Text] [Related]

  • 13. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
    Palareti G, Legnani C, Cosmi B, Valdré L, Lunghi B, Bernardi F, Coccheri S.
    Circulation; 2003 Jul 22; 108(3):313-8. PubMed ID: 12847064
    [Abstract] [Full Text] [Related]

  • 14. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
    Palareti G, Legnani C, Cosmi B, Guazzaloca G, Pancani C, Coccheri S.
    Thromb Haemost; 2002 Jan 22; 87(1):7-12. PubMed ID: 11848459
    [Abstract] [Full Text] [Related]

  • 15. [Measurement of prothrombin fragment F1+2 for monitoring the anticoagulant effect of phenprocoumon].
    Bruhn HD, Zurborn KH.
    Dtsch Med Wochenschr; 1993 Jul 02; 118(26):967-70. PubMed ID: 8519230
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The use of prothrombin fragment F1+2 to monitor the effect of oral anticoagulation.
    Bruhn HD, Zurborn KH.
    J Heart Valve Dis; 1995 Mar 02; 4(2):138-40. PubMed ID: 8556173
    [Abstract] [Full Text] [Related]

  • 18. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
    Martinelli I, Battaglioli T, Bucciarelli P, Passamonti SM, Mannucci PM.
    Circulation; 2004 Aug 03; 110(5):566-70. PubMed ID: 15262837
    [Abstract] [Full Text] [Related]

  • 19. Increased left atrial thrombin generation in mitral stenosis is not reflected in arterial prothrombin fragment 1+2 levels.
    Peverill RE, Harper RW, Gan TE, Smolich JJ.
    Clin Sci (Lond); 2000 Apr 03; 98(4):501-6. PubMed ID: 10731487
    [Abstract] [Full Text] [Related]

  • 20. Plasma coagulation markers in patients with solid tumors and venous thromboembolic disease receiving oral anticoagulation therapy.
    Sallah S, Husain A, Sigounas V, Wan J, Turturro F, Sigounas G, Nguyen NP.
    Clin Cancer Res; 2004 Nov 01; 10(21):7238-43. PubMed ID: 15534097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.